During the past decade, Esophageal Institute of Atlanta, PC. conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Esophageal Institute of Atlanta, PC." are "GERD Gastroesophageal Reflux Disease" (1 trials) and "Gastroesophageal Reflux Disease (GERD)" (1 trials). Many other conditions were trialed in "Esophageal Institute of Atlanta, PC." in a lesser frequency.

Most popular intervention types in "Esophageal Institute of Atlanta, PC." are "Device" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "LINX Reflux Management System" (1 trials), "LINX device" (1 trials) and "Omeprazole" (1 trials). Other intervention names were less common.

The vast majority of trials in "Esophageal Institute of Atlanta, PC." are 2 trials for "All" genders.

Currently, there are NaN active trials in "Esophageal Institute of Atlanta, PC.". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Esophageal Institute of Atlanta, PC., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Esophageal Institute of Atlanta, PC., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".